TCA
RMD icon

Transcend Capital Advisors’s ResMed RMD Stock Holding History

Transcend Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Buy
+908
New +$226K 0.02% 681
2025
Q2 		– Sell
-1,405
Closed -$315K – 700
2025
Q1 		$315K Sell
1,405
-61
-4% -$14.2K 0.02% 466
2024
Q4 		$335K Buy
+1,466
New +$353K 0.02% 418

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transcend Capital Advisors's RMD Position: Q1 2026 in Review

Transcend Capital Advisors opened a new position in ResMed (RMD) in Q1 2026: 908 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #681 among its holdings. This is a return to the name: Transcend Capital Advisors previously reported a position in RMD as recently as Q1 2025.

Transcend Capital Advisors first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. The position peaked at $335K in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Transcend Capital Advisors held 908 shares of ResMed worth $204K as of Q1 2026.
  • ResMed was a new Transcend Capital Advisors position in Q1 2026.
  • ResMed made up 0.02% of Transcend Capital Advisors's portfolio in Q1 2026, its #681 holding.
  • Transcend Capital Advisors first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
  • Transcend Capital Advisors's ResMed position peaked at $335K in Q4 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.